← Back to headlines
Barclays Initiates Amgen Coverage
Barclays has begun coverage of Amgen, noting a balanced outlook despite ongoing debate surrounding its trials.
23 Feb, 02:25 — 23 Feb, 02:25
ℹOnly 1 source covers this story
Barclays has begun coverage of Amgen, noting a balanced outlook despite ongoing debate surrounding its trials.